Johnson & Johnson (JNJ)
NYSE: JNJ
· Real-Time Price · USD
179.71
1.98 (1.11%)
At close: Sep 26, 2025, 3:59 PM
179.85
0.08%
After-hours: Sep 26, 2025, 07:49 PM EDT
Johnson & Johnson Revenue Breakdown
| Period Ending | Jun 29, 2025 | Mar 30, 2025 | Dec 29, 2024 | Sep 29, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Oct 1, 2023 | Oct 3, 2010 | Jul 4, 2010 |
|---|---|---|---|---|---|---|---|---|---|---|
| Innovative Medicine Revenue | 15.2B | 8.02B | 14.33B | 14.58B | 14.49B | 13.56B | 13.72B | 13.89B | 5.92B | 6.13B |
| Innovative Medicine Revenue Growth | +89.55% | -44.04% | -1.70% | +0.62% | +6.84% | -1.17% | -1.23% | +134.68% | -3.43% | n/a |
| MedTech Revenue | 8.54B | 13.87B | 8.19B | 7.89B | 7.96B | 7.82B | 7.67B | 7.46B | n/a | n/a |
| MedTech Revenue Growth | -38.43% | +69.43% | +3.76% | -0.83% | +1.74% | +1.93% | +2.88% | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Jun 29, 2025 | Mar 30, 2025 | Dec 29, 2024 | Sep 29, 2024 | Jun 30, 2024 | Mar 31, 2024 | Oct 1, 2023 | Jul 2, 2023 | Apr 2, 2023 | Jan 1, 2023 | Oct 2, 2022 | Jul 3, 2022 | Apr 3, 2022 | Jan 2, 2022 | Oct 3, 2021 | Jul 4, 2021 | Apr 4, 2021 | Jan 3, 2021 | Sep 27, 2020 | Jun 28, 2020 | Mar 29, 2020 | Dec 29, 2019 | Sep 29, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 30, 2018 | Sep 30, 2018 | Jul 1, 2018 | Apr 1, 2018 | Dec 31, 2017 | Oct 1, 2017 | Jul 2, 2017 | Apr 2, 2017 | Jan 1, 2017 | Oct 2, 2016 | Jul 3, 2016 | Apr 3, 2016 | Jan 3, 2016 | Sep 27, 2015 | Jun 28, 2015 | Mar 29, 2015 | Dec 28, 2014 | Sep 28, 2014 | Jun 29, 2014 | Mar 30, 2014 | Dec 29, 2013 | Sep 29, 2013 | Jun 30, 2013 | Mar 31, 2013 | Dec 30, 2012 | Sep 30, 2012 | Jul 1, 2012 | Apr 1, 2012 | Jan 1, 2012 | Oct 2, 2011 | Jul 3, 2011 | Apr 3, 2011 | Oct 3, 2010 | Jul 4, 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asia-Pacific, Africa Revenue | 3.61B | 3.31B | 3.26B | 3.48B | 3.45B | 3.41B | 3.46B | 4.48B | 4.31B | 3.83B | 4.25B | 4.2B | 4.51B | 4.26B | 4.29B | 4.36B | 4.37B | 3.99B | 3.88B | 3.6B | 3.66B | 3.81B | 3.99B | 3.97B | 3.78B | 3.58B | 3.72B | 3.84B | 3.69B | 3.48B | 3.48B | 3.38B | 3.08B | 3.1B | 3.21B | 3.28B | 2.98B | 3.07B | 3.05B | 3.22B | 3B | 3.31B | 3.36B | 3.44B | 3.33B | 6.7B | 3.33B | 3.35B | 4.48B | 4.6B | 3.98B | 4.17B | 4.19B | 8.46B | 4.12B | 4.54B | 4.18B | 2.8B | 2.69B |
| Asia-Pacific, Africa Revenue Growth | +8.91% | +1.56% | -6.19% | +0.67% | +1.35% | -1.48% | -22.82% | +3.92% | +12.56% | -9.95% | +1.19% | -6.75% | +5.85% | -0.72% | -1.61% | -0.32% | +9.55% | +2.83% | +7.78% | -1.69% | -3.98% | -4.36% | +0.45% | +5.05% | +5.62% | -3.74% | -3.18% | +3.95% | +6.18% | -0.11% | +2.99% | +9.95% | -0.87% | -3.36% | -2.04% | +9.89% | -2.96% | +0.92% | -5.52% | +7.36% | -9.22% | -1.52% | -2.47% | +3.39% | -50.27% | +101.14% | -0.72% | -25.15% | -2.65% | +15.57% | -4.37% | -0.69% | -50.44% | +105.19% | -9.22% | +8.61% | +49.50% | +4.21% | n/a |
| Europe Revenue | 5.39B | 5.11B | 4.92B | 4.91B | 5.21B | 5.16B | 4.73B | 5.89B | 6.33B | 5.82B | 5.52B | 6.08B | 6.02B | 6.92B | 5.59B | 5.67B | 5.41B | 5.27B | 4.82B | 4.06B | 4.83B | 4.66B | 4.46B | 4.73B | 4.61B | 4.73B | 4.42B | 4.81B | 4.8B | 4.73B | 4.31B | 4.23B | 3.86B | 4B | 3.83B | 4.09B | 3.85B | 4B | 3.8B | 4.15B | 4.04B | 4.56B | 4.45B | 5.06B | 4.88B | 4.97B | 4.48B | 4.67B | 8.03B | n/a | 7.79B | 7.36B | 7.22B | n/a | 6.87B | 7.45B | 7.61B | 3.63B | 3.83B |
| Europe Revenue Growth | +5.42% | +3.84% | +0.14% | -5.75% | +0.99% | +9.22% | -19.80% | -6.92% | +8.87% | +5.29% | -9.22% | +1.01% | -13.01% | +23.95% | -1.43% | +4.69% | +2.71% | +9.38% | +18.61% | -15.83% | +3.52% | +4.53% | -5.75% | +2.69% | -2.56% | +7.11% | -8.19% | +0.27% | +1.46% | +9.75% | +1.80% | +9.69% | -3.57% | +4.41% | -6.31% | +6.32% | -3.87% | +5.26% | -8.41% | +2.75% | -11.40% | +2.56% | -12.06% | +3.50% | -1.67% | +10.94% | -4.15% | -41.78% | n/a | n/a | +5.86% | +1.95% | n/a | n/a | -7.77% | -2.12% | +109.64% | -5.30% | n/a |
| Western Hemisphere, Excluding U.S. Revenue | 1.21B | 1.17B | 13.2B | 1.17B | 1.21B | 1.19B | 1.17B | 1.71B | 1.59B | 12.52B | 1.56B | 1.54B | 1.48B | 1.46B | 1.5B | 1.37B | 1.42B | 1.4B | 1.3B | 1.13B | 1.5B | 1.5B | 1.49B | 1.46B | 1.5B | 10.63B | 10.66B | 10.64B | 9.95B | 10.47B | 10.29B | 9.73B | 9.38B | 9.54B | 9.38B | 9.57B | 9.32B | 9.29B | 8.79B | 8.91B | 8.69B | 1.78B | 1.82B | 1.86B | 1.7B | 3.67B | 1.84B | 1.91B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 7.13B | 7.44B |
| Western Hemisphere, Excluding U.S. Revenue Growth | +3.34% | -91.16% | +1025.66% | -3.22% | +1.51% | +1.96% | -31.64% | +7.94% | -87.32% | +701.28% | +1.69% | +3.64% | +1.58% | -2.73% | +9.73% | -4.00% | +1.42% | +8.33% | +14.39% | -24.57% | +0.47% | +0.47% | +2.27% | -3.19% | -85.86% | -0.33% | +0.23% | +6.92% | -4.95% | +1.74% | +5.80% | +3.71% | -1.67% | +1.66% | -2.00% | +2.69% | +0.30% | +5.71% | -1.35% | +2.52% | +387.77% | -2.09% | -2.31% | +9.91% | -53.86% | +99.46% | -3.31% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4.13% | n/a |
| United States Revenue | 13.54B | 12.3B | 1.14B | 12.91B | 12.57B | 11.62B | 12B | 13.44B | 12.52B | 1.54B | 12.45B | 12.2B | 11.41B | 12.16B | 11.96B | 11.92B | 11.11B | 11.81B | 11.09B | 9.54B | 10.7B | 10.77B | 10.79B | 10.4B | 10.13B | 1.46B | 1.55B | 1.54B | 1.57B | 1.52B | 1.57B | 1.5B | 1.45B | 1.47B | 1.4B | 1.54B | 1.33B | 1.44B | 1.46B | 1.5B | 1.64B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| United States Revenue Growth | +10.07% | +984.14% | -91.21% | +2.71% | +8.17% | -3.13% | -10.77% | +7.41% | +710.16% | -87.59% | +2.10% | +6.86% | -6.16% | +1.67% | +0.37% | +7.27% | -5.91% | +6.52% | +16.22% | -10.84% | -0.70% | -0.16% | +3.73% | +2.71% | +595.67% | -6.06% | +0.65% | -1.72% | +3.16% | -3.19% | +4.67% | +3.09% | -0.75% | +4.94% | -9.47% | +15.85% | -7.70% | -1.44% | -2.53% | -8.42% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jun 29, 2025 | Mar 30, 2025 | Dec 29, 2024 | Sep 29, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Oct 1, 2023 | Jul 2, 2023 | Apr 2, 2023 | Jan 1, 2023 | Oct 2, 2022 | Jul 3, 2022 | Apr 3, 2022 | Jan 2, 2022 | Oct 3, 2021 | Jul 4, 2021 | Apr 4, 2021 | Jan 3, 2021 | Sep 27, 2020 | Jun 28, 2020 | Mar 29, 2020 | Dec 29, 2019 | Sep 29, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 30, 2018 | Sep 30, 2018 | Jul 1, 2018 | Apr 1, 2018 | Dec 31, 2017 | Oct 1, 2017 | Jul 2, 2017 | Apr 2, 2017 | Jan 1, 2017 | Oct 2, 2016 | Jul 3, 2016 | Apr 3, 2016 | Jan 3, 2016 | Sep 27, 2015 | Jun 28, 2015 | Mar 29, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 5.89B | 5.01B | 6.25B | 5.28B | 5.48B | 5.06B | 5.51B | 5.1B | 5B | 4.51B | 7.41B | 4.67B | 5.93B | 5.64B | 7.65B | 5.8B | 5.97B | 5.23B | 6.46B | 5.33B | 4.89B | 5.2B | 6.04B | 5.37B | 5.55B | 5.22B | 5.99B | 5.54B | 5.74B | 5.26B | 6.03B | 5.42B | 5.29B | 4.76B | 5.31B | 4.77B | 5.18B | 4.69B | 5.89B | 5.08B | 5.38B | 4.85B |
| Selling, General, and Administrative Revenue Growth | +17.50% | -19.85% | +18.47% | -3.70% | +8.38% | -8.22% | +8.04% | +2.08% | +10.87% | -39.21% | +58.55% | -21.11% | +5.11% | -26.34% | +31.97% | -2.90% | +14.16% | -18.97% | +21.12% | +8.95% | -5.96% | -13.84% | +12.37% | -3.10% | +6.27% | -12.89% | +8.08% | -3.48% | +9.12% | -12.65% | +11.10% | +2.53% | +11.04% | -10.28% | +11.25% | -7.81% | +10.41% | -20.42% | +15.94% | -5.63% | +11.08% | n/a |
| Research and Development Revenue | 3.52B | 3.23B | 5.3B | 4.95B | 3.44B | 3.54B | 4.48B | 3.45B | 3.7B | 3.46B | 4.62B | 3.48B | 3.7B | 4.07B | 4.72B | 3.42B | 3.39B | 3.18B | 4.03B | 2.84B | 2.71B | 2.58B | 3.23B | 2.6B | 2.67B | 2.86B | 3.22B | 2.51B | 2.64B | 2.4B | 3.63B | 2.58B | 2.3B | 2.07B | 2.64B | 2.18B | 2.26B | 2.01B | 2.86B | 2.15B | 2.13B | 1.9B |
| Research and Development Revenue Growth | +9.02% | -39.13% | +6.99% | +43.95% | -2.88% | -20.94% | +29.97% | -6.91% | +7.18% | -25.28% | +32.68% | -5.89% | -9.06% | -13.73% | +37.93% | +0.82% | +6.80% | -21.18% | +41.97% | +4.91% | +4.92% | -20.17% | +24.36% | -2.51% | -6.72% | -11.35% | +28.55% | -4.96% | +9.78% | -33.87% | +40.62% | +12.59% | +10.92% | -21.59% | +21.21% | -3.80% | +12.47% | -29.71% | +32.96% | +1.17% | +12.11% | n/a |